Silver Book

Silver Book Fact

Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually

Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.

Rboerts R, Hota B, Ahmad I, Scott R, et al. Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship. Clin Infect Dis. 2009; 49(8): 1175-84. http://cid.oxfordjournals.org/content/49/8/1175.full

Reference

Title
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implicatons for antibiotic stewardship
Publication
Clin Infect Dis
Publication Date
2009
Authors
Rboerts R, Hota B, Ahmad I, Scott R, et al.
Volume & Issue
Volume 49, Issue 8
Pages
1175-84
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Publications

Healthcare-Associated Infections Factsheet

 https://www.silverbook.org/wp-content/uploads/2015/06/Screen-Shot-2015-06-30-at-3.02.28-PM.png Thumbnail

Related Facts

  • Drug-resistant infections increase length & cost of hospital stays
    Drug-resistant infections increase the length of hospital stays by more than 23% and the cost by close to 30%.  
  • MRSA kills more than emphysema, HIV/AIDS, Parkinson’s, and homicide combined
    In one year, MRSA killed more Americans (~19,000) than emphysema, HIV/AIDS, Parkinson’s disease, and homicide combined.  
  • ~70% of hospital HAIs resistant to ≥ antimicrobial
    Approximately 70% of hospital-acquired HAIs are resistant to at least one antimicrobial drug.  
  • 1 in 4 inpatient pneumonia hospitalizations due to HAIs
    In one study, one in four inpatient pneumonia hospitalizations were from health-care-associated pneumonia.  
  • Antibacterial resistant pathogens responsible for most of 99,000 HAI related deaths
    The majority of the 99,000 patients who die from healthcare-associated infections each year, are due to antibacterial-resistant pathogens.